Stock A003000 BUKWANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Bukwang Pharmaceutical Co., Ltd.

Equities

A003000

KR7003000007

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-01 pm EDT 		5-day change 1st Jan Change
5,390 KRW -0.55% Intraday chart for Bukwang Pharmaceutical Co., Ltd. +0.94% -11.64%
May. 14 Bukwang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 H Delta Private Equity Partnership completed the acquisition of 24.4% stake in Contera Pharma ApS from Bukwang Pharmaceutical Co., Ltd. for KRW 6.3 billion. CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Bukwang Pharmaceutical : IR Fact Book 4Q23 (Reviewed by External Auditor)
PU
Bukwang Pharmaceutical : IR presentation 4Q23 (Reviewed by External Auditor)
PU
Bukwang Pharmaceutical : confirmed Levovir showed tendency of reducing virus from Phase 2 clinical trial topline data
PU
Bukwang Pharmaceutical : increased the number of patients for the clinical trial of covid-19 treatment
PU
Bukwang Pharmaceutical : Melior Pharmaceuticals Announces Positive Phase 2A Results in Type 2 Diabetes Study
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A003000 Stock
  4. News Bukwang Pharmaceutical Co., Ltd.
  5. Press Releases